tradingkey.logo

Globe Life Inc

GL
146.510USD
-0.440-0.30%
Close 02/06, 16:00ETQuotes delayed by 15 min
11.77BMarket Cap
10.27P/E TTM

Globe Life Inc

146.510
-0.440-0.30%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Globe Life Inc

Currency: USD Updated: 2026-02-06

Key Insights

Globe Life Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 114 in the Insurance industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 169.60.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Globe Life Inc's Score

Industry at a Glance

Industry Ranking
12 / 114
Overall Ranking
89 / 4521
Industry
Insurance

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Globe Life Inc Highlights

StrengthsRisks
Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company’s segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 5.99B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 7.90%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 7.90%.
Fairly Valued
The company’s latest PE is 10.27, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 68.43M shares, decreasing 8.44% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 37.85K shares of this stock.

Analyst Rating

Based on 12 analysts
Buy
Current Rating
169.600
Target Price
+15.41%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Globe Life Inc is 7.82, ranking 27 out of 114 in the Insurance industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 1.52B, representing a year-over-year increase of 3.64%, while its net profit experienced a year-over-year increase of 4.27%.

Score

Industry at a Glance

Previous score
7.82
Change
0

Financials

5.79

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.95

Operational Efficiency

7.83

Growth Potential

10.00

Shareholder Returns

8.55

Globe Life Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Globe Life Inc is 7.16, ranking 63 out of 114 in the Insurance industry. Its current P/E ratio is 10.27, which is 31.57% below the recent high of 13.51 and 54.80% above the recent low of 4.64.

Score

Industry at a Glance

Previous score
7.16
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 12/114
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Globe Life Inc is 7.67, ranking 25 out of 114 in the Insurance industry. The average price target is 167.00, with a high of 188.00 and a low of 145.00.

Score

Industry at a Glance

Previous score
7.67
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 12 analysts
Buy
Current Rating
169.600
Target Price
+15.41%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

19
Total
8
Median
8
Average
Company name
Ratings
Analysts
Globe Life Inc
GL
12
Prudential Financial Inc
PRU
18
MetLife Inc
MET
17
Corebridge Financial Inc
CRBG
15
Lincoln National Corp
LNC
14
Aflac Inc
AFL
14
1
2
3
4

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Globe Life Inc is 8.93, ranking 48 out of 114 in the Insurance industry. Currently, the stock price is trading between the resistance level at 154.34 and the support level at 137.05, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.00
Change
-0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(1)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
1.587
Buy
RSI(14)
67.229
Neutral
STOCH(KDJ)(9,3,3)
68.324
Sell
ATR(14)
3.118
Low Volatility
CCI(14)
126.922
Buy
Williams %R
35.859
Buy
TRIX(12,20)
0.090
Sell
StochRSI(14)
75.433
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
145.074
Buy
MA10
141.959
Buy
MA20
140.904
Buy
MA50
139.043
Buy
MA100
137.704
Buy
MA200
132.823
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Globe Life Inc is 7.00, ranking 38 out of 114 in the Insurance industry. The latest institutional shareholding proportion is 85.95%, representing a quarter-over-quarter increase of 1.13%. The largest institutional shareholder is The Vanguard, holding a total of 10.07M shares, representing 12.65% of shares outstanding, with 0.71% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
9.98M
-2.69%
BlackRock Institutional Trust Company, N.A.
4.25M
-1.05%
State Street Investment Management (US)
3.24M
-3.45%
Wellington Management Company, LLP
2.81M
-29.04%
Geode Capital Management, L.L.C.
2.72M
-0.04%
Invesco Advisers, Inc.
2.52M
+2.08%
Dimensional Fund Advisors, L.P.
2.08M
+2.94%
AQR Capital Management, LLC
1.39M
-0.87%
Invesco Capital Management LLC
Star Investors
1.31M
-4.49%
Norges Bank Investment Management (NBIM)
1.27M
+25.84%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Insurance domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Globe Life Inc is 9.82, ranking 6 out of 114 in the Insurance industry. The company's beta value is 0.46. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
9.82
Change
0
Beta vs S&P 500 index
0.46
VaR
+2.45%
240-Day Maximum Drawdown
+14.88%
240-Day Volatility
+29.17%

Return

Best Daily Return
60 days
+3.06%
120 days
+3.06%
5 years
+20.17%
Worst Daily Return
60 days
-1.82%
120 days
-3.25%
5 years
-53.14%
Sharpe Ratio
60 days
+2.80
120 days
+0.74
5 years
+0.46

Risk Assessment

Maximum Drawdown
240 days
+14.88%
3 years
+61.71%
5 years
+61.71%
Return-to-Drawdown Ratio
240 days
+1.30
3 years
+0.20
5 years
+0.14
Skewness
240 days
+0.17
3 years
-10.32
5 years
-9.77

Volatility

Realised Volatility
240 days
+29.17%
5 years
+37.02%
Standardised True Range
240 days
+2.01%
5 years
+1.67%
Downside Risk-Adjusted Return
120 days
+118.71%
240 days
+118.71%
Maximum Daily Upside Volatility
60 days
+15.66%
Maximum Daily Downside Volatility
60 days
+11.13%

Liquidity

Average Turnover Rate
60 days
+0.76%
120 days
+0.80%
5 years
--
Turnover Deviation
20 days
-39.50%
60 days
-36.06%
120 days
-32.92%

Peer Comparison

Insurance
Globe Life Inc
Globe Life Inc
GL
8.03 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Essent Group Ltd
Essent Group Ltd
ESNT
8.87 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Arch Capital Group Ltd
Arch Capital Group Ltd
ACGL
8.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Renaissancere Holdings Ltd
Renaissancere Holdings Ltd
RNR
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AXIS Capital Holdings Ltd
AXIS Capital Holdings Ltd
AXS
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Everest Group Ltd
Everest Group Ltd
EG
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI